about
Prognostic relevance of gemistocytic grade II astrocytoma: gemistocytic component and MR imaging features compared to non-gemistocytic grade II astrocytoma.Up to 52 administrations of macrocyclic ionic MR contrast agent are not associated with intracranial gadolinium deposition: Multifactorial analysis in 385 patients.Clinical impact of preoperative brain MR angiography and MR imaging in candidates for liver transplantation: a propensity score-matching study in a single institution.Comparison of High-Resolution MR Imaging and Digital Subtraction Angiography for the Characterization and Diagnosis of Intracranial Artery Disease.Perfusion of surgical cavity wall enhancement in early post-treatment MR imaging may stratify the time-to-progression in glioblastoma.Multiparametric MRI as a potential surrogate endpoint for decision-making in early treatment response following concurrent chemoradiotherapy in patients with newly diagnosed glioblastoma: a systematic review and meta-analysis.Radiomics as a Quantitative Imaging Biomarker: Practical Considerations and the Current Standpoint in Neuro-oncologic Studies.Amide proton transfer imaging seems to provide higher diagnostic performance in post-treatment high-grade gliomas than methionine positron emission tomography.Diffusion-Weighted Imaging and Diffusion Tensor Imaging for Differentiating High-Grade Glioma from Solitary Brain Metastasis: A Systematic Review and Meta-Analysis.Perfusion MRI as a diagnostic biomarker for differentiating glioma from brain metastasis: a systematic review and meta-analysis.Joint approach of diffusion- and perfusion-weighted MRI in intra-axial mass like lesions in clinical practice simulationClinically Relevant Imaging Features for MGMT Promoter Methylation in Multiple Glioblastoma Studies: A Systematic Review and Meta-AnalysisImaging prediction of isocitrate dehydrogenase (IDH) mutation in patients with glioma: a systemic review and meta-analysisIdentification of Early Response to Anti-Angiogenic Therapy in Recurrent Glioblastoma: Amide Proton Transfer-weighted and Perfusion-weighted MRI compared with Diffusion-weighted MRIClinical Value of Vascular Permeability Estimates Using Dynamic Susceptibility Contrast MRI: Improved Diagnostic Performance in Distinguishing Hypervascular Primary CNS Lymphoma from GlioblastomaOptimized Image-Based Surrogate Endpoints in Targeted Therapies for Glioblastoma: A Systematic Review and Meta-Analysis of Phase III Randomized Controlled TrialsMRI Findings in Tumefactive Demyelinating Lesions: A Systematic Review and Meta-AnalysisAmide proton transfer-weighted MRI can detect tissue acidosis and monitor recovery in a transient middle cerebral artery occlusion model compared with a permanent occlusion model in ratsDevelopment and Validation of a Deep Learning System for Staging Liver Fibrosis by Using Contrast Agent-enhanced CT Images in the LiverReproducibility and Generalizability in Radiomics Modeling: Possible Strategies in Radiologic and Statistical PerspectivesPrediction of Core Signaling Pathway by Using Diffusion- and Perfusion-based MRI Radiomics and Next-generation Sequencing in Isocitrate Dehydrogenase Wild-type GlioblastomaQuality of science and reporting of radiomics in oncologic studies: room for improvement according to radiomics quality score and TRIPOD statementA systematic review reporting quality of radiomics research in neuro-oncology: toward clinical utility and quality improvement using high-dimensional imaging featuresPrimary Central Nervous System Lymphoma: Diagnostic Yield of Whole-Body CT and FDG PET/CT for Initial Systemic ImagingA Good Practice-Compliant Clinical Trial Imaging Management System for Multicenter Clinical Trials: Development and Validation StudyFalse-Positive Measurement at 2-Hydroxyglutarate MR Spectroscopy in Isocitrate Dehydrogenase Wild-Type Glioblastoma: A Multifactorial AnalysisRadiological Recurrence Patterns after Bevacizumab Treatment of Recurrent High-Grade Glioma: A Systematic Review and Meta-Analysis
P50
Q39178578-C31A9EDE-70D2-40CF-AF0D-6E27141C9306Q40062884-60B288E0-75F1-49DD-9E09-91FCD793DDE2Q40370517-9A8CEB68-F555-4AD8-82C2-8788EBB41224Q40407257-8BCEE370-65B3-4CB8-A32F-CD7BD88E855EQ41090550-32183701-CA4C-4B18-BA53-AC1C84A615E6Q48157495-A7903D2C-87FE-4AE6-B09E-5CD04FDE9747Q53073424-3026E03F-C7FA-45D1-B9D8-0B5F5E607306Q53081393-FD674B7D-6496-4DED-8633-5190DDE90546Q55457202-21C62509-BD7B-42CA-BFE4-2C9AE0D56C92Q55457351-4CCFFC17-8BD7-4E53-A2C4-20C2EA9C232AQ58760144-016E499E-8946-440A-8BE5-35779E5D24FFQ90006011-6261B76A-95CD-46AD-8AE8-5E0C18D262DCQ90019041-75CC6483-724A-443E-9E4E-A9CEE744FEE2Q90184612-5F8A3EF8-9A59-4B96-8AEA-E4FF798AA116Q90349935-2C2159E0-D028-49BE-8AF8-785A464D622DQ90474535-7A7D32CB-4D16-4849-82D9-18393F94AF03Q90987134-BC0D6BD5-E612-4AD3-8E17-B916B95CD5D0Q91149998-399C300F-5C7B-4453-9B35-DA8B4A6CEB21Q91281078-A14CEB65-90DE-4680-8B0E-2334FE353A33Q91599684-FBC59CCB-D119-4609-B3D1-28B9C5EEE287Q92039065-03E8D482-1D6F-4C3F-92D6-922E7E080906Q92215978-87C9162A-5D88-4638-A022-FC40721352E3Q92559461-4B513844-13BA-445E-9AC0-84D4289A7C08Q93011152-A89A6852-03C5-41FD-B527-F7610782521AQ93026788-CF84D0EC-5F05-4728-B70B-823CDD1C7631Q93124632-194D62B0-0C4A-4243-9B59-CC4CD3818039Q96308385-B35256F4-D708-4D4D-B052-C9C67094696A
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Ho Sung Kim
@en
Ho Sung Kim
@nl
type
label
Ho Sung Kim
@en
Ho Sung Kim
@nl
prefLabel
Ho Sung Kim
@en
Ho Sung Kim
@nl
P31
P496
0000-0002-9477-7421